Supernus Pharmaceuticals | SUPN - Ordinary Share Capital


Supernus Pharmaceuticals reported $58.04M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Aurora Cannabis CAD 56.71M 134.13K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 368.28M 35.9M Dec/2025
Cara Therapeutics USD 9.38M 9.38M Sep/2025
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Eisai JPY 282.11M 0 Mar/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Novo Nordisk DKK 4.44B 0 Dec/2025
Pacira USD 39.31M 1.81M Mar/2026
Perrigo USD 138.1M 500K Mar/2026
Pfizer USD 5.7B 13M Mar/2026
Supernus Pharmaceuticals USD 58.04M 582K Mar/2026
United Therapeutics USD 42.16M 1.49M Mar/2026
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025